Dr Andrew Harvey - QEDDI, a partner for small molecule drug discovery

The Queensland Emory Drug Discovery Initiative (QEDDI), a business unit of UniQuest, is a dedicated small molecule drug discovery and development capability. It has core capabilities and expertise in medicinal chemistry, compound screening, discovery biology and preclinical drug development. QEDDI’s experts, recruited from industry, collaborate with academic partners to translate innovative biology research in to new drug candidates addressing serious unmet need for commercialisation.  

In this seminar, UniQuest’s Dr Andrew Harvey will provide an overview of QEDDI’s capabilities and facilities, and show how QEDDI can help you progress your project in a collaborative drug discovery program.